$OMGA News
Last published 1y ago
- 1y agoFHTXMRNAOMGASANAFlagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and InnovationPR NewswireFlagship Pioneering, the bioplatform innovation company, today announced an agreement with top life science organisations Cambridge University Health ...
- 1y agoFHTXMRNAOMGASANAFlagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and InnovationPR NewswireFlagship Pioneering, the bioplatform innovation company, today announced an agreement with top life science organisations Cambridge University Health ...
- 1y agoFHTXMRNAOMGASANAFlagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore BiotechnologiesPR NewswireFlagship Pioneering, the bioplatform innovation company, and Metaphore Biotechnologies, a Flagship-founded biotechnology company designing novel...
- 1y agoFHTXMRNAOMGASANAFlagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with PfizerPR NewswireFlagship Pioneering, the bioplatform innovation company, today announced Ampersand Biomedicines and Montai Therapeutics have entered into agreements...
- 1y agoOMGAOmega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial ResultsGlobeNewswireEstablished clinical proof-of-mechanism and validation of epigenomic controllers as potential new class of medicines from completed Phase 1 MYCHELANGELO™ I trial for c-MYC in HCC; Company exploring strategic
- 1y agoFHTXMRNAOMGASANAFlagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori BioPR NewswireFlagship Pioneering, the bioplatform innovation company, and Apriori Bio, a biotechnology company aimed at providing humanity with variant-resilient...
- 1y agoFHTXMRNAOMGASANABrian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-PartnerPR NewswireFlagship Pioneering, the bioplatform innovation company, and Valo Health today announced that industry leader Brian M. Alexander, M.D., M.P.H. has...
- 2y agoFHTXMRNAOMGASANAFlagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering IntelligencePR NewswireFlagship Pioneering, the bioplatform innovation company, today announced that Junaid Bajwa, M.D., has joined its London office as Senior Partner and...
- 2y agoOMGAOmega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific MeetingsGlobeNewswireCAMBRIDGE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (NASDAQ:OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA
- 2y agoFHTXMRNAOMGASANAFlagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital SolutionsPR NewswireFlagship Pioneering, the bioplatform innovation company, today announced that Paul Parker has joined as Managing Partner, Capital Solutions and Value ...
- 2y agoFHTXMRNAOMGASANAInvaio Sciences Appoints André Andonian as Chairman of the Board of DirectorsPR NewswireInvaio Sciences, a Flagship Pioneering bioplatform company focused on accelerating the leap to nature-positive agriculture, today announced the...
- 2y agoFHTXMRNAOMGASANAA*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in SingaporePR NewswireThe Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, and Flagship Pioneering, the bioplatform...
- 2y agoAPREIARTOMGAHalda Therapeutics Appoints Veteran Biopharma Leader, Christian Schade, as President and Chief Executive OfficerBusiness WireBrings proven leadership and successful track record to Halda as the company enters the next stage of growth as clinical-stage company Halda Therapeutics, a biotechnology company developing a novel class of cancer
- 2y agoFHTXMRNAOMGASANAFlagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech IndustryPR NewswireFlagship Pioneering, the bioplatform innovation company, today unveiled Mirai Bio, a company pioneering the first open end-to-end platform for the...
- 2y agoOMGAOmega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature CommunicationsGlobeNewswireTreatment with OTX-2002 led to controlled downregulation of MYC gene expression and resulted in significant inhibition of tumor growth as a monotherapy and in combination with standard of care agents in preclinical
- 2y agoOMGAOmega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of ResearchGlobeNewswireCAMBRIDGE, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (NASDAQ:OMGA) ("Omega"), a biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today
- 2y agoOMGAOmega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company ProgressGlobeNewswireAdvanced MYCHELANGELO™ I trial; Company expects to select recommended dose for expansion and initiate monotherapy and combination expansion cohorts in fourth quarter of 2024Reinforced diverse capabilities of the
- 2y agoFHTXMRNAOMGASANAFlagship Pioneering Announces Appointment of Raj Panjabi as Senior PartnerPR NewswireFlagship Pioneering, the bioplatform innovation company, today announced that globally distinguished healthcare expert, entrepreneur, and public...
- 2y agoGSKFHTXMRNAOMGA+1GSK and Flagship Pioneering partner to discover novel medicines and vaccinesPR NewswireGSK plc (LSE/NYSE: GSK) and Flagship Pioneering (Flagship), the bioplatform innovation company, today announced they have entered a collaboration...
- 2y agoADIFHTXMRNAOMGA+1Analog Devices and Flagship Pioneering Announce Strategic Partnership to Accelerate the Development of a Fully Digitized Biological WorldPR NewswireAnalog Devices, Inc. (Nasdaq: ADI), a global semiconductor leader, and Flagship Pioneering, the bioplatform innovation company, today announced a...
- 2y agoAPREOMTHNRGMEDX+11Alltrna Announces Updates to Its Board of DirectorsPR NewswireAlltrna, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and...
- 2y agoOMGAOmega Therapeutics Announces Election of Richard N. Kender to Board of DirectorsGlobeNewswireCAMBRIDGE, Mass., June 24, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (NASDAQ:OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA
- 2y agoDNLIFHTXMRNAOMGA+2Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with PfizerPR NewswireFlagship Pioneering and ProFound™ Therapeutics, a Flagship-founded company pioneering the expanded human proteome to develop novel medicines for a...
- 2y agoOMGAOmega Therapeutics To Participate In Two Upcoming Investor ConferencesGlobeNewswireCAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (NASDAQ:OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA
- 2y agoOMGAOmega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business OfficerGlobeNewswireCAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (NASDAQ:OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA
- 2y agoDNLIFHTXMRNAOMGA+2Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity ManagementPR NewswireMetaphore Biotechnologies, a Flagship-founded biotechnology company designing novel therapeutics by combining machine learning and molecular mimicry, ...
- 2y agoOMGAOmega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic ControllersGlobeNewswireProgrammable epigenomic mRNA candidates enabled durable and robust upregulation of gene expression across a diverse set of gene types and regulatory mechanismsAdditional OMEGA platform capabilities demonstrated,
- 2y agoDNLIFHTXMCRBMRNA+2Flagship Pioneering Unveils Prologue Medicines to Unlock the Therapeutic Potential of the Viral ProteomeBusiness WireThe company's DELVE™ Platform combines computation and high-throughput biology to systematically discover the therapeutic potential of proteins tuned through millennia of viral evolution The company emerges
- 2y agoOMGAOmega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressGlobeNewswireAdvanced MYCHELANGELO™ I trial dose escalation to Cohort 5; Presentation of additional monotherapy data and planned expansion into Phase 2 settings expected in mid-2024Presented new preclinical data demonstrating
- 2y agoOMGAOmega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual MeetingGlobeNewswireCAMBRIDGE, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (NASDAQ:OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA
- 2y agoOMGAOmega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic ControlGlobeNewswireMYC-directed epigenomic controller exerts anti-tumor effect in preclinical models of EGFR inhibitor-resistant NSCLC regardless of underlying resistance mechanismValidation of novel translational assay enables detection
- 2y agoDNLIFHTXMRNAOMGA+2Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio SciencesPR NewswireFlagship Pioneering, the bioplatform innovation company, and Invaio Sciences, a bioplatform company accelerating the leap to nature-positive...
- 2y agoOMGAOmega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic UpdateGlobeNewswireAdvanced OTX-2002 in MYCHELANGELO™ I trial; initial cohorts demonstrated encouraging disease control rate in late-stage HCC patientsEstablished a research collaboration with Novo Nordisk to develop an epigenomic
- 2y agoDNLIFHTXMRNAOMGA+2Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024PR NewswireFlagship Pioneering, the bioplatform innovation company, has been named to Fast Company's prestigious list of the World's Most Innovative Companies...
- 2y agoOMGAOmega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024GlobeNewswireCAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (NASDAQ:OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA
- 2y agoDNLIFHTXMRNAOMGA+2DEAN BANKS APPOINTED CEO OF INDIGO AG AND CEO-PARTNER OF FLAGSHIP PIONEERINGPR NewswireFlagship Pioneering, the bioplatform innovation company, and Indigo Ag, an innovative leader and trusted partner in sustainable agriculture, today...
- 2y agoDNLIFHTXMRNAOMGA+2Flagship Pioneering Debuts Enabling Technologies InitiativePR NewswireFlagship Pioneering, the bioplatform innovation company, today announced the formation of a new strategic initiative to foster enabling technologies...
- 2y agoDNLIFHTXMRNAOMGA+2Flagship Pioneering and Samsung Announce Collaboration to Advance Groundbreaking Technologies in Translational Science and MedicinePR NewswireFlagship Pioneering, the bioplatform innovation company, and Samsung today announced a collaboration aimed at fostering cutting-edge...
- 2y agoDNLIFHTXMCRBMRNA+2Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering MedicinesBusiness Wire- Research aims to leverage Sail's Endless RNA™ (eRNA™) platform as a novel therapeutic approach to treating the 10%-15% of people with cystic fibrosis (CF) who are genetically defined as ineligible for,
- 2y agoOMGANovo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseasesGlobeNewswireOmega collaboration will leverage the company's platform to develop an epigenomic controller as part of a new approach to obesity managementCellarity collaboration will build upon initial work and engage the company's
- 2y agoOMGAOmega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceGlobeNewswireCAMBRIDGE, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (NASDAQ:OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA
- 2y agoOMGAOmega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual ConferenceGlobeNewswireCAMBRIDGE, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (NASDAQ:OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA
- 2y agoDNLIFHTXMCRBMRNA+3Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life SciencesBusiness WireThermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and Flagship Pioneering, the bioplatform innovation company, today announced the formation of a strategic partnership to develop and
- 2y agoDNLIFHTXMRNAOMGA+2Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science LeadersPR NewswireFlagship Pioneering, the bioplatform innovation company, today marked the official launch of its UK presence with an event co-hosted in partnership...
- 2y agoDNLIFHTXMRNAOMGA+2Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science LeadersPR NewswireFlagship Pioneering, the bioplatform innovation company, today marked the official launch of its UK presence with an event co-hosted in partnership...
- 2y agoDNLIFHTXMRNAOMGA+2Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of GeneticsPR NewswireFlagship Pioneering, the bioplatform innovation company, today unveiled Quotient Therapeutics, a company pioneering somatic genomics, the study of...
- 2y agoOMGAOmega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare ConferenceGlobeNewswireCAMBRIDGE, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (NASDAQ:OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA
- 2y agoOMGAOmega Therapeutics Showcases Bidirectional and Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and FibrosisGlobeNewswireFirst-ever demonstration of sustained pre-transcriptional upregulation of gene expression by an epigenomic controller in both in vitro and in vivo models of liver fibrosis Single epigenomic controller demonstrated
- 3y agoOMGAOmega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company ProgressGlobeNewswireAnnounced promising preliminary clinical data for OTX-2002 from ongoing MYCHELANGELO™ I trial; clinical proof-of-platform established with potential applicability across a broad range of diseasesAdvanced OMEGA
- 3y agoOMGAOmega Therapeutics to Participate in The Jefferies London Healthcare ConferenceGlobeNewswireCAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (NASDAQ:OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA